Teleflex Incorporated Stock Price and Value Analysis

Teleflex Incorporated (NYSE:TFX) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Teleflex Incorporated to reach your target.

Target type

TFX Free Cash Flow Trend

Free Cash Flow trendline for TFX
Free Cash Flow trendline for Teleflex Incorporated
CSV

Based on historical returns, we believe that Teleflex Incorporated can grow its free cash at a rate of about 3%. That's positive!

AdvantagesDisadvantages
  • This stock is on sale.
  • This company has a low dividend yield.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This company is less known than others.

Inside the TFX Numbers

TFX Price
(Teleflex Incorporated stock price per share)
$163.40
[?] TFX Fair Price
(based on intrinsic value)
$212.68
[?] TFX Safety Price (based on a variable margin of safety) $127.61
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 297% higher than other Healthcare stocks
[?] PE Ratio versus Industry 76% higher than other Medical Devices stocks
[?] Cash Yield 5.63%
[?] Free Cash Flow Jitter 57%
[?] Dividend Yield 0.82% (tax impact)
Shares Shorted 4,066,318

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 4,066,318 shares shorted. With 39,500,633 shares available for purchase and an average trading volume over the past 10 trading days of 970,740, it would take at least 4.2 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2008 96943 51
2009 96943 90.6
2010 96943 114
2011 96943 61.1
2012 96943 155
2013 96943 185
2014 96943 236
2015 96943 243
2016 96943 348
2017 96943 363
2018 96943 368
2019 96943 363
2020 96943 357
2021 96943 569
2022 96943 258
2023 96943 128
2024 96943 226
2025 96943 20.1

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 16 fiscal years from 2008 to 2025 with positive net income, operating cash flow totaled $4,916 million against net income of $4,193 million, or 1.17 times. Net income was negative in 2 of the 18 years, and those years are left out of the ratio.

In 2025, net income was -$906 million and operating cash flow was $96.7 million, so no ratio is shown for that year.

In 2025, capital expenditures were $95.2 million, 98.5% of operating cash flow of $96.7 million, which leaves an estimated $1.4 million after capex. Across the 18 years with reported capex, it averaged 22.5% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2008 120 83.7 32.7 0.70
2009 303 120 26.3 0.40
2010 201 144 29.3 0.72
2011 323 94.4 44.6 0.29
2012 -190 195 65.4 n/a
2013 151 231 63.6 1.53
2014 188 290 67.6 1.55
2015 245 303 61.4 1.24
2016 237 411 53.1 1.73
2017 153 426 70.9 2.79
2018 201 435 80.8 2.17
2019 461 437 103 0.95
2020 335 437 90.7 1.30
2021 485 652 71.6 1.34
2022 363 343 79.2 0.94
2023 356 206 46.4 0.58
2024 69.7 302 90.4 4.33
2025 -906 96.7 95.2 n/a

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $3,001 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 10 of those years with dividend payment facts, dividends paid totaled $624 million, 20.8% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 9 of those 10 years.

In 2 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $500 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, dividends and cash spent repurchasing shares together were $360 million, 1792.2% of estimated free cash flow of $20.1 million. That was more than the estimated free cash flow of the year.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2016 348 59 n/a 59 16.9%
2017 363 61.2 n/a 61.2 16.9%
2018 368 62.2 n/a 62.2 16.9%
2019 363 62.8 n/a 62.8 17.3%
2020 357 63.2 n/a 63.2 17.7%
2021 569 63.6 n/a 63.6 11.2%
2022 258 63.8 n/a 63.8 24.7%
2023 128 63.9 n/a 63.9 49.9%
2024 226 63.5 200 264 116.5%
2025 20.1 60.3 300 360 1792.2%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $1,912 million in 2008 and $1,993 million in 2025, a compound annual growth rate of 0.2% over 17 years.

Revenue rose 17.2% from 2024 to 2025.

Our estimated free cash flow was $20.1 million in 2025, 1.0% of revenue. In 2008 the estimated margin was 2.7%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2008 1,912 51 2.7%
2009 1,435 90.6 6.3%
2010 1,398 114 8.2%
2011 1,493 61.1 4.1%
2012 1,551 155 10.0%
2013 1,696 185 10.9%
2014 1,840 236 12.8%
2015 1,810 243 13.4%
2016 1,868 348 18.6%
2017 2,146 363 16.9%
2018 2,448 368 15.0%
2019 2,595 363 14.0%
2020 2,537 357 14.1%
2021 2,810 569 20.2%
2022 2,791 258 9.2%
2023 1,712 128 7.5%
2024 1,700 226 13.3%
2025 1,993 20.1 1.0%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $379 million against total liabilities of $3,822 million, or 9.9% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 55.0% of total assets in 2025, compared with 58.7% in 2009, a decrease of 3.7 percentage points.

Stockholders equity was $3,125 million in 2025, compared with $1,585 million in 2009, a rise of 97.1%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 0.3% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2009 3,839 188 2,254 1,585
2010 3,643 208 1,856 1,787
2011 3,924 584 1,941 1,983
2012 3,734 337 1,952 1,782
2013 4,209 432 2,293 1,916
2014 3,923 303 2,009 1,914
2015 3,872 338 1,861 2,011
2016 3,891 544 1,754 2,138
2017 6,181 334 3,751 2,431
2018 6,278 357 3,738 2,540
2019 6,310 301 3,331 2,979
2020 7,153 376 3,816 3,336
2021 6,872 445 3,117 3,755
2022 6,928 292 2,906 4,022
2023 7,533 223 3,092 4,441
2024 7,098 248 2,820 4,278
2025 6,947 379 3,822 3,125

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $163.40, our model's value equals that price if free cash flow grows an average of -2.8 percent a year over the 10 projection years. Our model assumes 3.5 percent a year for this stock, so the price implies growth of -2.8 percent, which is below the 3.5 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

A negative rate means the price matches our model's value only if free cash flow shrinks by that average each year over the 10 years.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $365 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $130.72 -9.8%
Current price $163.40 -2.8%
20 percent above the current price $196.08 1.7%
Our model (stored fair price) $212.68 3.5%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Every one of the 18 fiscal years we have for Teleflex Incorporated under its current filer shows positive free cash flow.

The price of $163.40 is above our safe value ($127.61) but still below the fair value estimate of $212.68 for Teleflex Incorporated.

Comparing the first and last three years of data, average free cash flow rose sharply: $85.3 million at the start and $125 million most recently.

Year-to-year variability in free cash flow is volatile, measured at 57%.

Teleflex Incorporated pays a dividend yield of 0.82%.

Our value investing guide explains how to test these numbers against the filings themselves.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 297% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is 76% above the average for stocks in the Medical Devices industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Medical Devices industry, the ones closest in market capitalization to Teleflex Incorporated, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
Teleflex Incorporated (TFX) 6,481 80.5 0.8% 5.6% 23% below
Haemonetics Corporation (HAE) 5,481 53.3 - 1.7% 133% above
LivaNova PLC (LIVN) 5,072 26.4 - - 323% above
Merit Medical Systems (MMSI) 5,057 31.6 - 1.1% 117% above
ICU Medical (ICUI) 4,396 73.5 - 1.4% 32% above
Integer Holdings Corporation (ITGR) 4,317 42.6 - - 147% above
Globus Medical (GMED) 9,088 16.9 - - 65% above

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 96943.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-19
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: TFX annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in TFX

Does Teleflex Incorporated have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: TFX

This example shows how we apply the Trendshare checklist to TFX: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 163.40
    • Market cap: $6.5B
    • EPS: 2.03
  2. Step 2 — Valuation checks

    • P/E: 80.493
    • FCF yield: 5.6%
    • Date checked: Nov 19, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.